Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

被引：0
|
作者：
Che-kai Tsao
Alexander C. Small
Max Kates
Erin L. Moshier
Juan P. Wisnivesky
Benjamin A. Gartrell
Guru Sonpavde
James H. Godbold
Michael A. Palese
Simon J. Hall
William K. Oh
Matthew D. Galsky
机构：
[1] Mount Sinai School of Medicine,Division of Hematology and Medical Oncology, The Tisch Cancer Institute
[2] Mount Sinai School of Medicine,Department of Medicine
[3] Texas Oncology,Department of Medicine, Section of Medical Oncology, Michael E. DeBakey Veterans Affairs Medical Center
[4] Baylor College of Medicine,Department of Urology
[5] Mount Sinai School of Medicine,undefined
来源：
World Journal of Urology | 2013年 / 31卷
关键词：
Cytoreductive nephrectomy; SEER; Targeted therapy; Tyrosine kinase inhibitor; Disparities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1535 / 1539
页数：4
相关论文
共 50 条
  • [41] The Impact of Targeted Therapy on Management of Metastatic Renal Cell Carcinoma: Trends in Systemic Therapy and Cytoreductive Nephrectomy Utilization
    Psutka, Sarah P.
    Kim, Simon P.
    Gross, Cary P.
    Van Houten, Holly
    Thompson, R. Houston
    Abouassaly, Robert
    Weight, Christopher
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Shah, Nilay D.
    UROLOGY, 2015, 85 (02) : 442 - 450
  • [42] The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies
    Claeys, Tom
    Lumen, Nicolaas
    Kumps, Candy
    Praet, Marleen
    De Meerleer, Gert
    Rottey, Sylvie
    Ost, Piet
    Devisschere, Pieter
    Villeirs, Geert
    Fonteyne, Valerie
    Decaestecker, Karel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04) : 152.e13 - 152.e22
  • [43] Survival following upfront cytoreductive nephrectomy versus targeted therapy for metastatic renal cell carcinoma.
    Bhindi, Bimal
    Habermann, Elizabeth Butzer
    Mason, Ross
    Costello, Brian Addis
    Pagliaro, Lance C.
    Thompson, Robert Houston
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy
    Cortese, Brian D.
    Chelluri, Raju
    Xia, Leilei
    Ostrowski, David A.
    Roberson, Daniel S.
    Strother, Marshall
    Ding, James M.
    Schwartz, Lauren
    Lee, Daniel J.
    Guzzo, Thomas J.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (05): : 327 - 333
  • [45] PROGNOSTIC SIGNIFICANCE OF SARCOMATOID FEATURES IN METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND TARGETED THERAPY
    Chelluri, Raju
    Xia, Leilei
    Taylor, Benjamin
    Raman, Jay
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2018, 199 (04): : E869 - E870
  • [46] Postoperative complications from cytoreductive nephrectomy after neoadjuvant targeted therapy for metastatic renal cell carcinoma
    Chapin, B. F.
    Delacroix, S. E., Jr.
    Culp, S. H.
    Gonzalez, G.
    Wood, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [47] Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective
    Shaw, Greg L.
    Hussain, Mahreen
    Nair, Rajesh
    Bycroft, John
    Beltran, Luis
    Green, James S. A.
    Powles, Thomas
    Peters, John L.
    UROLOGIA INTERNATIONALIS, 2012, 89 (01) : 83 - 88
  • [48] POPULATION-BASED TRENDS AND OUTCOMES FOR CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES
    Wiesen, Brett
    Achua, Justin
    Warren, Adam
    Gershman, Boris
    Eule, Corbin
    Kim, Simon
    JOURNAL OF UROLOGY, 2024, 211 (05): : E849 - E850
  • [49] Cytoreductive nephrectomy plus targeted therapy versus targeted therapy alone in metastatic renal cell carcinoma: a retrospective cohort study
    Choi, S. W.
    Fok, C. Y.
    Teoh, J. Y.
    Hou, S. M.
    Ng, C. F.
    BJU INTERNATIONAL, 2017, 119 : 11 - 12
  • [50] Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature
    Mazzaschi, Giulia
    Quaini, Federico
    Bersanelli, Melissa
    Buti, Sebastiano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
12345